Cryoimmunology for malignant bone and soft-tissue tumors

International Journal of Clinical Oncology

Volumn 16, Issue 2, 2011, Pages 109-117

  Nishida, Hideji ^a   Yamamoto, Norio ^a   Tanzawa, Yoshikazu ^a   Tsuchiya, Hiroyuki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Bone and soft tissue sarcoma; Cryoimmunology; Cryotreatment; Immunotherapy

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; DENDRITIC CELL VACCINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMATINIB; INTERLEUKIN 2; PACLITAXEL; SORAFENIB;

ANGIOSARCOMA; BONE CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CHONDROSARCOMA; CRYOABLATION; CRYOSURGERY; DENDRITIC CELL; DRUG RESPONSE; FIBROSARCOMA; GERM CELL TUMOR; HUMAN; IMMUNE RESPONSE; INTERMETHOD COMPARISON; MOLECULARLY TARGETED THERAPY; MONOTHERAPY; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; REVIEW; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANIMALS; BONE NEOPLASMS; COMBINED MODALITY THERAPY; CRYOSURGERY; HUMANS; IMMUNOTHERAPY; MICE; MOLECULAR TARGETED THERAPY; OSTEOSARCOMA; SOFT TISSUE NEOPLASMS;

EID: 79959839181     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0218-2     Document Type: Review

References (60)

1. Bacci G, Longhi A, Versari M et al (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106:1154-1161
2. Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20:776-790 (Pubitemid 34111386)
3. Meyers PA, Schwartz CL, Krailo M et al (2005) Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 23:2004-2011 (Pubitemid 46211380)
4. Provisor AJ, Ettinger LJ, Nachman JB et al (1997) Treatment of non-metastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 15:76-84 (Pubitemid 27020560)
5. Tsuchiya H, Yasutake H, Yokogawa A et al (1992) Effect of chemotherapy combined with caffeine for osteosarcoma. J Cancer Res Clin Oncol 118:567-569
6. Tsuchiya H, Tomita K, Mori Y et al (1999) Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop Relat Res 358:27-35 (Pubitemid 29066071)
7. Tsuchiya H, Tomita K, Mori Y et al (1998) Caffeine-assisted chemotherapy and minimized tumor excision for non-metastatic osteosarcoma. Anticancer Res 18:657-666 (Pubitemid 28174888)
8. Tsuchiya H, Kanazawa Y, Abdel-Wanis ME et al (2002) Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study. J Clin Oncol 20:3470-3477
9. Pacey S, Ratain MJ, Flaherty KT et al (2011) Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial. Invest New Drugs [Epub ahead of print]
10. Maki RG, D'Adamo DR, Keohan ML et al (2009) Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol 27:3133-3140
11. Kuenen BC, Tabernero J, Baselga J et al (2003) Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma. Clin Cancer Res 9:1648-1655 (Pubitemid 36554587)
12. Stopeck A, Sheldon M, Vahedian M et al (2002) Results of a phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies. Clin Cancer Res 8:2798-2805 (Pubitemid 35025722)
13. D'Adamo DR, Anderson SE, Albritton K et al (2005) Phase II study of doxorubicin and bevacizumab for patients with metastatic soft tissue sarcomas. J Clin Oncol 23:7135-7142
14. Fuller CK, Charlson JA, Dankle SK et al (2010) Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. J Am Acad Dermatol 63:83-84
15. Jordan K, Wolf HH, Voigt W et al (2010) Bevacizumab in combination with sequential high-dose chemotherapy in solid cancer, a feasibility study. Bone Marrow Transplant 45:1704-1709
16. Sleijfer S, Ray-Coquard I, Papai Z et al (2009) Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol 27:3126-3132
17. Sugiura H, Fujiwara Y, Ando M et al (2010) Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma. J Orthop Sci 15:654-660
18. Grignani G, Palmerini E, Stacchiotti S et al (2010) A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -α: an Italian Sarcoma Group study. Cancer 117:826-831
19. Luksch R, Perotti D, Cefalo G et al (2003) Immunomodulation in a treatment program including pre- and post-operative interleukin-2 and chemotherapy for childhood osteosarcoma. Tumori 3:263-268 (Pubitemid 37014116)
20. Geiger J, Hutchinson R, Hohenkirk L et al (2000) Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells. Lancet 356:1163-1165
21. Tabarkiewicz J, Radej S, Hus I et al (2008) Dendritic cells based immunotherapy of patient with chondrosarcoma - case report. Folia Histochem Cytobiol 46:165-170
22. Ohta H, Hashii Y, Yoneda A et al (2009) WT1 (Wilms tumor 1) peptide immunotherapy for childhood rhabdomyosarcoma: a case report. Pediatr Hematol Oncol 26:74-83
23. Ayyoub M, Taub RN, Keohan ML et al (2004) The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma. Cancer Immun 4:7
24. Segal NH, Blachere NE, Guevara-Patino JA et al (2005) Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics. Cancer Immun 5:2
25. Mackall CL, Rhee EH, Read EJ et al (2008) A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin Cancer Res 14:4850
26. Gage A (1998) History of cryosurgery. Semin Surg Oncol 14:99-109
27. Flanders VL, Gervais DA (2010) Ablation of liver metastases: current status. J Vasc Interv Radiol 21:S214-S222
28. Huang A, McCall JM, Weston MD et al (2002) Phase I study of percutaneous cryotherapy for colorectal liver metastasis. Br J Surg 89:303-310 (Pubitemid 34227028)
29. Chin JL, Lim D, Abdelhady M (2007) Review of primary and salvage cryo-ablation for prostate cancer. Cancer Control 14:231-237 (Pubitemid 47057792)
30. Atwell TD, Farrell MA, Callstrom MR et al (2007) Percutaneous cryo-ablation of large renal masses: technical feasibility and short-term outcome. AJR Am J Roentgenol 188:1195-1200 (Pubitemid 46668496)
31. Sabel MS, Kaufman CS, Whitworth P et al (2004) Cryo-ablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial. Ann Surg Oncol 11:542-549 (Pubitemid 40486738)
32. Karlsson JO, Cravalho EG, Borel Rinkes IH et al (1993) Nucleation and growth of ice crystals inside cultured hepatocytes during freezing in the presence of dimethyl sulfoxide. Biophys J 65:2524-2536 (Pubitemid 24005986)
33. Hoffmann NE, Bischof JC (2002) The cryobiology of cryosurgical injury. Urology 60:40-49
34. Sidana A, Chowdhury WH, Fuchs EJ et al (2010) Cryoimmunotherapy in urologic oncology. Urology 75:1009-1014
35. Marcove RC, Miller TR, Cahan WC et al (1968) The treatment of primary and metastatic bone tumors by repetitive freezing. Acad Med 44:532-544
36. Biesecker JL, Marcove RC, Huvos AG et al (1970) Aneurysmal bone cysts. A clinicopathologic study of 66 cases. Cancer 26:615-625
37. Marcove RC, Weis LD, Vaghaiwalla MR et al (1978) Cryosurgery in the treatment of giant cell tumors of bone. A report of 52 consecutive cases. Cancer 41:957-969
38. Huvos AG, Marcove RC (1973) Chondroblastoma of bone. A critical review. Clin Orthop Relat Res 95:300-312
39. Marcove RC, Miké V, Hutter RV et al (1972) Chondrosarcoma of the pelvis and upper end of the femur. An analysis of factors influencing survival time in one hundred and thirteen cases. J Bone Joint Surg Am 54:561-572
40. Marcove RC, Abou Zahr K, Huvos AG et al (1984) Cryosurgery in osteogenic sarcoma: report of three cases. Compr Ther 10:52-60 (Pubitemid 14196061)
41. Tsuchiya H, Wan SL, Sakayama K et al (2005) Reconstruction using an autograft containing tumour treated by liquid nitrogen. J Bone Joint Surg Br 87:218-225 (Pubitemid 40278024)
42. Tsuchiya H, Nishida H, Srisawat P et al (2010) Pedicle frozen autograft reconstruction in malignant bone tumors. J Orthop Sci 15:340-349
43. Yantorno C, Soanes WA, Gonder MJ et al (1967) Studies in cryoimmunology. I. The production of antibodies to urogenital tissue in consequence of freezing treatment. Immunology 12:395-410
44. Shulman S, Brandt EJ, Yantorno C (1968) Studies in cryoimmunology. II. Tissue and species specificity of the autoantibody response and comparison with iso-immunization. Immunology 14:149-158
45. Ablin RJ (1972) Cryoimmunotherapy. Br Med J 3:476
46. Soanes WA, Gonder MJ, Ablin RJ (1970) A possible immuno-cryothermic response in prostatic cancer. Clin Radiol 21:253-255
47. Neel HB III, Ketcham AS, Hammond WG (1973) Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation. Laryngoscope 83:376-387
48. Bagley DH, Faraci RP, Marrone JC et al (1974) Lymphocyte mediated cytotoxicity after cryosurgery of a murine sarcoma. J Surg Res 17:404-406
49. Misao A, Sakata K, Saji S et al (1981) Late appearance of resistance to tumor rechallenge following cryosurgery. A study in an experimental mammary tumor of the rat. Cryobiology 18:386-389
50. Joosten JJ, Muijen GN, Wobbes T et al (2001) In vivo destruction of tumor tissue by cryoablation can induce inhibition of secondary tumor growth: an experimental study. Cryobiology 42:49-58
51. Sabel MS, Nehs MA, Su G et al (2005) Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat 90:97-104 (Pubitemid 40487008)
52. Steinman RM (2003) Some interfaces of dendritic cell biology. APMIS 111:675-697
53. den Brok MH, Sutmuller RP, Nierkens S et al (2006) Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer 95:896-905 (Pubitemid 44498106)
54. Urano M, Tanaka C, Sugiyama Y et al (2003) Anti-tumor effects of residual tumor after cryo-ablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model. Cryobiology 46:238-245 (Pubitemid 36724565)
55. Lubaroff DM, Reynolds CM, Canfield L (1981) Immunologic aspects of the prostate. Prostate 23:233-248
56. Udagawa M, Saito CK, Hasegawa G et al (2006) Enhancement of immunologic tumor regression by intra-tumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and bacillus Calmette-Guerin cell wall skeleton stimulation. Clin Cancer Res 12:7465-7475 (Pubitemid 46095422)
57. Machlenkin A, Goldberger O, Tirosh B et al (2005) Combined dendritic cell cryosurgery of tumor induces systemic antimetastatic immunity. Clin Cancer Res 11:4955-4961 (Pubitemid 41557217)
58. Osada S, Imai H, Tomita H et al (2007) Serum cytokine levels in response to hepatic cryoablation. J Surg Oncol 95:491-498 (Pubitemid 46709393)
59. Nishida H, Tsuchiya H, Tomita K (2008) Re-implantation of tumour tissue treated by cryotreatment with liquid nitrogen induces anti-tumour activity against murine osteosarcoma. J Bone Joint Surg Br 90:1249-1255
60. Kawano M, Nishida H, Nakamoto Y et al (2010) Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma. Clin Orthop Relat Res 468:1373-1383